These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 27234731)

  • 1. Evaluation of Changes in New Calculated Panel Reactive Antibody Adopting HLA-Cw, DR51/52/53, and DQ Antigens in Koreans.
    In JW; Roh EY; Shin S; Park KU; Song EY
    Transplant Proc; 2016 Apr; 48(3):766-9. PubMed ID: 27234731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corrected Panel-Reactive Antibody Positivity Rates for Hypersensitized Patients in Turkish Population With Calculated Panel-Reactive Antibody Software.
    Karadeniz ST; Akgul SU; Ogret Y; Ciftci HS; Bayraktar A; Bakkaloglu H; Caliskan Y; Yelekci K; Turkmen A; Aydin AE; Oguz FS; Carin M; Aydin F
    Transplant Proc; 2017 Apr; 49(3):445-447. PubMed ID: 28340809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of calculated panel reactive antibody using HLA frequencies in Koreans.
    Jang JY; Kim YJ; Kim Y; Park YJ; Han K; Oh EJ
    Ann Lab Med; 2012 Jan; 32(1):66-72. PubMed ID: 22259781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of calculated panel reactive antibody and its potential benefits in improving the kidney allocation strategy in Taiwan.
    Shen SW; Chang CK; Gao YS; Hsu PJ; Cheng SC; Liu FY; Lo SC
    J Formos Med Assoc; 2017 Dec; 116(12):956-963. PubMed ID: 29037453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allocating Deceased Donor Kidneys to Candidates with High Panel-Reactive Antibodies.
    Gebel HM; Kasiske BL; Gustafson SK; Pyke J; Shteyn E; Israni AK; Bray RA; Snyder JJ; Friedewald JJ; Segev DL
    Clin J Am Soc Nephrol; 2016 Mar; 11(3):505-11. PubMed ID: 26839235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Calculated panel reactive antibody method for assessing the probability of kidney recipients to receive transplantation].
    Luo M; Yu L; Xiao L
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Apr; 34(4):477-81. PubMed ID: 24752091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portuguese calculated panel reactive antibodies online estimator.
    Lima BA; Alves H
    HLA; 2019 Jun; 93(6):445-450. PubMed ID: 30838808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABO-adjusted calculated panel reactive antibody (cPRA): A unified metric for immunologic compatibility in kidney transplantation.
    Gragert L; Kadatz M; Alcorn J; Stewart D; Chang D; Gill J; Liwski R; Gebel HM; Gill J; Lan JH
    Am J Transplant; 2022 Dec; 22(12):3093-3100. PubMed ID: 35975734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cPRA Increases With DQA, DPA, and DPB Unacceptable Antigens in the Canadian cPRA Calculator.
    Tinckam KJ; Liwski R; Pochinco D; Mousseau M; Grattan A; Nickerson P; Campbell P
    Am J Transplant; 2015 Dec; 15(12):3194-201. PubMed ID: 26080906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simplified method of calculating cPRA for kidney allocation application in Hong Kong: a retrospective study.
    Chan YP; Wong MWK; Tang LWM; Guo M; Yang W; Ip P; Li PKT; Leung CB; Chau KF; Lam JCK; Yeung NKM; Kwok JSY
    Transpl Int; 2017 Dec; 30(12):1234-1242. PubMed ID: 28777478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Casting a smaller net into a bigger donor pool: A single center's experience with the new kidney allocation system.
    Houp JA; Schillinger KP; Eckstein AJ; Vega RM; Desai NM; Lonze BE; Jackson AM
    Hum Immunol; 2017 Jan; 78(1):49-53. PubMed ID: 27890719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 infection and vaccination rarely impact HLA antibody profile in waitlisted renal transplant candidates- a multicenter cohort.
    Roll GR; Bray RA; Cooper M; Eagar TN; Gebel HM; Vranic GM; Hitchman KMK; Houp J; Kamoun M; Killian J; Kim J; Kumar V; Levine M; Lovasik BP; Lunow-Luke T; Parsons RF; Pattanayak V; Ranch D; Shah A; Stock PG; Timofeeva OA; Trofe-Clark J; Wongjirad C; Yeh H; Yi S; Rajalingam R
    Hum Immunol; 2023 Apr; 84(4):278-285. PubMed ID: 36868898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calculated panel reactive antibody with decimals: A refined metric of access to transplantation for highly sensitized candidates.
    Kransdorf EP; Pando MJ
    Hum Immunol; 2017 Mar; 78(3):252-256. PubMed ID: 28069404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CPRA for allocation of kidneys in the US: More candidates ≥98% CPRA, lower positive crossmatch rates and improved transplant rates for sensitized patients.
    Baxter-Lowe LA; Kucheryavaya A; Tyan D; Reinsmoen N
    Hum Immunol; 2016 May; 77(5):395-402. PubMed ID: 27012168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parsing the 100% calculated panel reactive antibody kidney transplant candidates: Who gets transplanted?
    Keith DS
    HLA; 2020 Jan; 95(1):23-29. PubMed ID: 31515960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-DQ barrier: effects on cPRA calculations.
    Tambur AR; Leventhal JR; Walsh RC; Zitzner JR; Friedewald JJ
    Transplantation; 2013 Dec; 96(12):1065-72. PubMed ID: 23995957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Iranian panel reactive antibody calculator and potential usefulness: A retrospective study.
    Mohammadzadeh S; Jaladat AR; Mohammadi M; Geramizadeh B; Anbardar MH; Soleimani N; Amirinezhad Fard E; Tehrani NJ
    Clin Transplant; 2022 Nov; 36(11):e14789. PubMed ID: 35933599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Introduction of cPRA and Its Impact on Access to Deceased Donor Kidney Transplantation for Highly Sensitized Patients in Australia.
    Sypek MP; Kausman JY; Watson N; Wyburn K; Holt SG; Hughes P; Clayton PA
    Transplantation; 2021 Jun; 105(6):1317-1325. PubMed ID: 34019363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Calculated Panel Reactive Antigen Is Associated With Increased Waitlist Time and Mortality in Lung Transplantation.
    Barac YD; Mulvihill MS; Jawitz O; Klapper J; Haney J; Daneshmand M; Nasir B; Chen D; Milano CA; Hartwig MG
    Ann Thorac Surg; 2020 Aug; 110(2):414-423. PubMed ID: 32251655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-A, B, C, DRB1, DQB1 matching heterogeneity in 'favourably matched' kidney recipients.
    Rees MT; Darke C
    Transpl Immunol; 2003; 12(1):73-8. PubMed ID: 14551034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.